The HIV-1 envelope glycoproteins: Fusogens, antigens, and immunogens

被引：1290

作者：

Wyatt, R

Sodroski, J ^{[1
]}

机构：

[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol AIDS,Dept Pathol, Boston, MA 02115 USA

[2] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA

来源：

SCIENCE | 1998年 / 280卷 / 5371期

关键词：

D O I：

10.1126/science.280.5371.1884

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

The human immunodeficiency virus-type 1 (HIV-1) envelope glycoproteins interact with receptors on the target cell and mediate virus entry by fusing the viral and cell membranes. The structure of the envelope glycoproteins has evolved to fulfill these functions while evading the neutralizing antibody response. An understanding of the viral strategies for immune evasion should guide attempts to improve the immunogenicity of the HIV-1envelope glycoproteins and, ultimately, aid in HIV-1vaccine development.

引用

页码：1884 / 1888

页数：5

共 176 条

[71] DIRECT IDENTIFICATION OF CLASS II HISTOCOMPATIBILITY DR PROTEINS IN PREPARATIONS OF HUMAN T-CELL LYMPHOTROPIC VIRUS TYPE-III
HENDERSON, LE
SOWDER, R
COPELAND, TD
OROSZLAN, S
ARTHUR, LO
ROBEY, WG
FISCHINGER, PJ
[J]. JOURNAL OF VIROLOGY, 1987, 61 (02) : 629 - 632
[72] Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor
Hill, CM
Deng, HK
Unutmaz, D
Kewalramani, VN
Bastiani, L
Gorny, MK
ZollaPazner, S
Littman, DR
[J]. JOURNAL OF VIROLOGY, 1997, 71 (09) : 6296 - 6304
[73] CONFORMATIONAL EPITOPE ON GP120 IMPORTANT IN CD4 BINDING AND HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEUTRALIZATION IDENTIFIED BY A HUMAN MONOCLONAL-ANTIBODY
HO, DD
MCKEATING, JA
XI, LL
MOUDGIL, T
DAAR, ES
SUN, NC
ROBINSON, JE
[J]. JOURNAL OF VIROLOGY, 1991, 65 (01) : 489 - 493
[74] QUANTITATION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 IN THE BLOOD OF INFECTED PERSONS
HO, DD
MOUDGIL, T
ALAM, M
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (24) : 1621 - 1625
[75] Modulation of feline immunodeficiency virus infection by stromal cell-derived factor
Hosie, MJ
Broere, N
Hesselgesser, J
Turner, JD
Hoxie, JA
Neil, JC
Willett, BJ
[J]. JOURNAL OF VIROLOGY, 1998, 72 (03) : 2097 - 2104
[76] NONRANDOM ASSOCIATION OF CELLULAR ANTIGENS WITH HTLV-III VIRIONS
HOXIE, JA
FITZHARRIS, TP
YOUNGBAR, PR
MATTHEWS, DM
RACKOWSKI, JL
RADKA, SF
[J]. HUMAN IMMUNOLOGY, 1987, 18 (01) : 39 - 52
[77] IDENTIFICATION OF ENVELOPE V3 LOOP AS THE MAJOR DETERMINANT OF CD4 NEUTRALIZATION SENSITIVITY OF HIV-1
HWANG, SS
BOYLE, TJ
LYERLY, HK
CULLEN, BR
[J]. SCIENCE, 1992, 257 (5069) : 535 - 537
[78] ALTERATION OF HIV-1 INFECTIVITY AND NEUTRALIZATION BY A SINGLE AMINO-ACID REPLACEMENT IN THE V3 LOOP DOMAIN
IVANOFF, LA
LOONEY, DJ
MCDANAL, C
MORRIS, JF
WONGSTAAL, F
LANGLOIS, AJ
PETTEWAY, SR
MATTHEWS, TJ
[J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (07) : 595 - 603
[79] HIV-1 INHIBITION BY A PEPTIDE
JIANG, SB
LIN, K
STRICK, N
NEURATH, AR
[J]. NATURE, 1993, 365 (6442) : 113 - 113
[80] INHIBITION OF HIV-1 INFECTION BY A FUSION DOMAIN BINDING PEPTIDE FROM THE HIV-1 ENVELOPE GLYCOPROTEIN-GP41
JIANG, SB
LIN, K
STRICK, N
NEURATH, AR
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 195 (02) : 533 - 538

← 3 4 5 6 7 8 9 10 11 12 →